Table 3.xls (9.5 kB)
Immune cells in ectocervical tissues at IVR removal [visit 7], based on treatment assignment.
dataset
posted on 2018-06-28, 17:57 authored by Andrea Ries Thurman, Jill L. Schwartz, Vivian Brache, Meredith R. Clark, Timothy McCormick, Neelima Chandra, Mark A. Marzinke, Frank Z. Stanczyk, Charlene S. Dezzutti, Sharon L. Hillier, Betsy C. Herold, Raina Fichorova, Susana N. Asin, Christiane Rollenhagen, Debra Weiner, Patrick Kiser, Gustavo F. DoncelCompleter population.
History
Usage metrics
Categories
Keywords
15 daysluteinizing hormone levelsimmunodeficiency virusTFV pharmacodynamic activity90 daysmucus sperm penetrationcell numbersLNG pharmacodynamic assessmentsCV aspirate TFV concentrationsTrial registration ClinicalTrials.govIVR uselaboratory measurementsvivo TFVLNG release ratessperm penetrationCV fluidmicrobiota changes1 hourIVR usersCONRADmucosal histologyLNG IVR usershealth burdensintravaginal ringTFV-containing IVRsTFV pharmacokineticsCVFserum LNG concentrationsDPHIV90 daymucus Insler score3 days post IVR removal86 womenepithelial integrityantimicrobial proteinsNCTdrug release data
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC